Clonidine hydrochloride: review of pharmacologic and clinical aspects.
D000450:Aldosterone / Q000378:metabolism; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects; D002492:Central Nervous System Depressants / Q000009:adverse effects; D003000:Clonidine / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007668:Kidney / Q000187:drug effects; D007700:Kinetics; D008750:Methyldopa / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D012083:Renin / Q000097:blood; D013375:Substance Withdrawal Syndrome / Q000209:etiology; D014665:Vasodilator Agents / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D002492:Central Nervous System Depressants; D004232:Diuretics; D014665:Vasodilator Agents; D000450:Aldosterone; D008750:Methyldopa; D011433:Propranolol; D012083:Renin; D003000:Clonidine; D011224:Prazosin